EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Chlamydia effector CpoS modulates the inclusion microenvironment and restricts the interferon response by acting on Rab35

Karsten Meier, Lana H Jachmann, Gözde Türköz, Mohammed Rizwan Babu Sait, Lucía Pérez, Oliver Kepp, Raphael H Valdivia, Guido Kroemer, Barbara S Sixt iD

mBio · 2023

DOI: 10.1128/mbio.03190-22 ↗

Kurz gefasst

Fachartikel in der Zeitschrift mBio, 2023. Verfasst von Karsten Meier und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Biology, Umeå University , Umeå, Sweden. Hauptthemen laut MEDLINE: Chlamydia Infections, Interferon Type I. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, HHS | National Institutes of Health (NIH), European Commission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The obligate intracellular bacterium Chlamydia trachomatis inserts a family of inclusion membrane (Inc) proteins into the membrane of its vacuole (the inclusion). The Inc CpoS is a critical suppressor of host cellular immune surveillance, but the underlying mechanism remained elusive. By complementing a cpoS mutant with various natural orthologs and variants of CpoS, we linked distinct molecular interactions of CpoS to distinct functions. Unexpectedly, we found CpoS to be essential for the formation of inclusion membrane microdomains that control the spatial organization of multiple Incs involved in signaling and modulation of the host cellular cytoskeleton. While the function of CpoS in microdomains was uncoupled from its role in the suppression of host cellular defenses, we found the ability of CpoS to interact with Rab GTPases to be required not only for the manipulation of membrane trafficking, such as to mediate transport of ceramide-derived lipids (sphingolipids) to the inclusion, but also for the inhibition of Stimulator of interferon genes (STING)-dependent type I interferon responses. Indeed, depletion of Rab35 phenocopied the exacerbated interferon responses observed during infection with CpoS-deficient mutants. Overall, our findings highlight the role of Inc–Inc interactions in shaping the inclusion microenvironment and the modulation of membrane trafficking as a pathogenic immune evasion strategy. IMPORTANCE Chlamydia trachomatis is a prevalent bacterial pathogen that causes blinding ocular scarring and urogenital infections that can lead to infertility and pregnancy complications. Because Chlamydia can only grow within its host cell, boosting the intrinsic defenses of human cells may represent a novel strategy to fight pathogen replication and survival. Hence, CpoS, a Chlamydia protein known to block host cellular defenses, or processes regulated by CpoS, could provide new opportunities for therapeutic intervention. By revealing CpoS as a multifunctional virulence factor and by linking its ability to block host cellular immune signaling to the modulation of membrane trafficking, the present work may provide a foundation for such rationale targeting and advances our understanding of how intracellular bacteria can shape and protect their growth niche.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Chlamydia InfectionsInterferon Type IHumansBacterial ProteinsChlamydia trachomatisImmune EvasionHeLa CellsHost-Pathogen Interactions

Stichwörter der Autor:innen

Rab GTPasescell-autonomous immunityinterferon responsesintracellular bacteriamembrane microdomainsmembrane trafficking

Substanzen

Bacterial ProteinsInterferon Type I

Autor:innen und Institutionen

  • Department of Molecular Biology, Umeå University , Umeå, Sweden.
  • The Laboratory for Molecular Infection Medicine Sweden (MIMS), Umeå University , Umeå, Sweden.
  • Umeå Centre for Microbial Research (UCMR), Umeå University , Umeå, Sweden.
  • Metabolomics and Cell Biology Platforms, Institut Gustave Roussy , Villejuif, France.
  • Centre de Recherche des Cordeliers, Equipe labellisée par la Ligue contre le cancer, Université de Paris, Sorbonne Université, Inserm U1138, Institut Universitaire de France , Paris, France.
  • Department of Molecular Genetics and Microbiology, Duke University School of Medicine , Durham, North Carolina, USA.

ORCID-Profile: Barbara S Sixt

Förderung

  • NIAID NIH HHS
  • HHS | National Institutes of Health (NIH)
  • European Commission
  • Vetenskapsrådet
  • Agence Nationale de la Recherche
  • Institute Nationale du Cancer
  • DIM ELICIT

Zitieren

APA

Meier, K., Jachmann, L. H., Türköz, G., Babu Sait, M. R., Pérez, L., Kepp, O., Valdivia, R. H., Kroemer, G., & Sixt, B. S. (2023). The Chlamydia effector CpoS modulates the inclusion microenvironment and restricts the interferon response by acting on Rab35. mBio. https://doi.org/10.1128/mbio.03190-22

Vancouver

Meier K, Jachmann LH, Türköz G, Babu Sait MR, Pérez L, Kepp O, et al. The Chlamydia effector CpoS modulates the inclusion microenvironment and restricts the interferon response by acting on Rab35. mBio. 2023. doi:10.1128/mbio.03190-22

BibTeX
@article{Meier2023,
  author = {Meier, Karsten and Jachmann, Lana H and Türköz, Gözde and Babu Sait, Mohammed Rizwan and Pérez, Lucía and Kepp, Oliver and Valdivia, Raphael H and Kroemer, Guido and Sixt, Barbara S},
  title = {The Chlamydia effector CpoS modulates the inclusion microenvironment and restricts the interferon response by acting on Rab35},
  journal = {mBio},
  year = {2023},
  doi = {10.1128/mbio.03190-22}
}
Kostenlos starten →